Target intelligence / Profile preview

Cell and bacterial membranes

Molecular classification
Lipid bilayer, Cellular structure, Biological barrier
01

Overview

Cell and bacterial membranes are essential lipid bilayers that define cellular boundaries and maintain the internal environment of all living organisms [6, 14]. In antimicrobial therapy, the bacterial membrane serves as a vital target for drugs like polymyxins and daptomycin, which disrupt its structural integrity or electrical potential [1, 3, 4]. These drugs often distinguish between bacterial and host membranes by targeting specific components like lipopolysaccharides or negatively charged phospholipids that are more prevalent in microbes [3, 4, 12]. Disruption of the membrane leads to the formation of pores, leakage of intracellular ions such as potassium, and eventual cell lysis [3, 5]. Beyond infection, the cell membrane is increasingly recognized as a target in oncology, where differences in membrane fluidity and charge in cancer cells are exploited by therapeutic peptides [6, 12]. However, the high degree of structural similarity between various biological membranes often leads to significant safety concerns, including nephrotoxicity and neurotoxicity [2, 5, 7]. Additionally, the cell membrane acts as a critical reservoir for many lipophilic drugs, influencing their distribution and duration of action [14, 17]. Understanding the biophysical interactions at the membrane interface is therefore crucial for both drug efficacy and the mitigation of adverse effects [7, 11].

Other names
Plasma membraneCytoplasmic membraneLipid bilayerBacterial cell envelopeInner and outer membranes
02

Mechanism of action

Disruption of membrane integrity, pore formation, depolarization of the membrane potential, and alteration of lipid bilayer fluidity, leading to leakage of intracellular contents and cell death.

03

Biological functions

Barrier functionSignal transductionIon homeostasisCompartmentalizationEnergy metabolism (ATP synthesis)Nutrient transport
04

Disease associations

InfectionCancerSepsisInflammation
05

Safety considerations

NephrotoxicityNeurotoxicityOtotoxicityHemolysisLack of selective toxicity between bacterial and host membranes
06

Interacting drugs

Polymyxin B

7 more in the full profile.

07

Biomarkers

Lactate dehydrogenase (LDH) releasePropidium iodide (PI) uptakeMembrane potential (e.g., DiSC3(5) fluorescence)Phosphatidylserine exposure

Beyond the preview

Go deeper on Cell and bacterial membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell and bacterial membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call